DRD3 and myeloid sarcoma: Conversely, low dopamine levels, through the stimulation of high-affinity DRs, including DRD3, DRD4 and DRD5, have been shown to promote inflammation in animal models of Parkinson’s disease [10–13], inflammatory bowel diseases [14, 15], allergic asthma [16], and MS [17–20].